Key facts
- This page summarizes Anand Kiran Parikh's Form 4 filing for Faeth Therapeutics, Inc. (FTH).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Nov 2026, 20:33.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Gift
Gift
Additional SEC filing notes
Footnote F1
Represents the number of the shares of the Issuer's Common Stock gifted to AKP Irrevocable Trust for the benefit of the Reporting Person's immediate family members.
Footnote F2
The shares are held of record by the AKP Irrevocable Trust, of which the Reporting Person's immediate family members are the beneficiaries. Preservation Trust Company serves as trustee, and the Reporting Person serves as investment advisor with authority to direct the trustee on the investment of trust assets. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.